Table of Contents
Overview
New York, NY – July 24, 2025 : The global stents market is projected to grow from US$ 14.8 billion in 2024 to approximately US$ 21.1 billion by 2034. This represents a compound annual growth rate (CAGR) of 3.6% during the forecast period from 2025 to 2034. North America continues to lead the global market, capturing more than a 43.5% revenue share. It holds a market value of around US$ 6.4 billion in 2024. This dominance is driven by a high demand for advanced medical devices and well-established healthcare infrastructure.
Rising cardiovascular disease cases remain a primary growth factor for the stents market. Stents are widely used in treating coronary artery disease to keep arteries open after procedures like angioplasty. The growing prevalence of lifestyle disorders such as obesity, hypertension, and diabetes has directly increased the number of cardiovascular procedures. These conditions raise the risk of arterial blockages, making stents a vital component of modern cardiac care.
Technological progress in stent design has significantly boosted market adoption. Innovations such as drug-eluting stents (DES) and bioresorbable stents offer better outcomes and lower complication risks. Drug-eluting stents release medication to prevent artery re-narrowing. Bioresorbable stents dissolve naturally over time, reducing long-term side effects. These advanced options improve patient recovery and lower the need for repeat procedures, making them attractive choices in clinical settings.
The increasing use of minimally invasive techniques further drives stent market expansion. Minimally invasive procedures offer shorter hospital stays, faster recovery, and reduced pain. These benefits make them preferable for both patients and healthcare providers. The growing shift toward less invasive cardiovascular treatments enhances the demand for newer, more efficient stent systems. As a result, medical device companies are investing heavily in R&D to meet this evolving need.
In July 2024, Shanghai MicroPort Medical (Group) Co., Ltd. gained approval from China’s NMPA for its Firesorb stent. This fully bioresorbable cardiac stent offers promising results in clinical trials. It matches traditional drug-eluting stents in performance, particularly in lumen loss and procedural success. Firesorb represents a major breakthrough in next-generation cardiac care. As more innovative products like this enter the market, opportunities for global growth and improved patient outcomes are set to rise steadily over the next decade.
Key Takeaways
- In 2024, the global stents market generated approximately US$ 14.8 billion, and it’s expected to reach US$ 21.1 billion by 2033.
- The market is projected to grow at a steady CAGR of 3.6% throughout the forecast period from 2024 to 2034.
- Vascular stents dominated the product type segment in 2024, accounting for a commanding 82.0% of the total market share.
- Non-vascular stents represented a smaller portion of the market, significantly trailing behind vascular stents in terms of usage and demand.
- Based on materials, metallic stents led the segment with a substantial 78.5% market share, reflecting their broad acceptance in clinical use.
- Non-metallic stents held a relatively smaller market share compared to metallic stents, indicating lower adoption in current medical practices.
- Hospitals emerged as the leading end-user, capturing 72.3% of the total market revenue in the stents sector during 2024.
- Ambulatory care centers and specialty clinics followed hospitals in end-user preference but held a comparatively smaller market portion.
- North America remained the top regional market, securing a dominant 43.5% share in the global stents market in 2024.
- The region’s strong position is attributed to advanced healthcare infrastructure and high rates of cardiovascular procedures.
Regional Analysis
North America is leading the Stents Market
North America held the largest revenue share of 43.5% in the global stents market. This growth is driven by the rising cases of cardiovascular diseases, increasing demand for interventional procedures, and rapid adoption of advanced technologies. Drug-eluting stents (DES) led the coronary stents segment in 2024. Key players like Abbott Laboratories and Medtronic have boosted innovation in the region. Favorable reimbursement policies and regulatory support have made stent procedures more accessible. Additionally, minimally invasive techniques and preventive healthcare trends continue to fuel market growth.
Asia Pacific is expected to experience the highest CAGR during the forecast period
Asia Pacific is projected to grow at the fastest CAGR, mainly due to high cardiovascular disease rates in countries like China and India. In 2024, China alone contributed a significant share to global stents revenue. Improved healthcare infrastructure and rising medical investments support this trend. Collaborations between global manufacturers and local providers are enhancing access to advanced stent technologies. An aging population, lifestyle changes, and preventive care initiatives are also boosting demand. Government efforts to improve healthcare access further drive regional market expansion.
Segmentation Analysis
Product Type Analysis:
In 2024, vascular stents led the market with a dominant share of 82.0%. This is due to the rising number of vascular conditions like coronary artery and peripheral artery diseases. These stents help prevent vessel narrowing and ensure proper blood flow. An aging population and unhealthy habits such as smoking, obesity, and diabetes are driving demand. Drug-eluting and bioresorbable stents are gaining popularity due to fewer complications. As minimally invasive procedures become a priority, vascular stents will continue to see steady market growth.
Material Analysis:
Metallic stents accounted for a strong 78.5% share in 2024. Their popularity stems from durability, flexibility, and proven results in cardiovascular care. These stents are typically made from stainless steel or cobalt-chromium alloys, which ensure lasting support. The growing use of drug-eluting metallic stents also boosts demand, as they help reduce restenosis. Technological improvements like better coatings and bioactive surfaces are further enhancing outcomes. With cardiovascular cases increasing globally, especially among seniors, the need for advanced metallic stents is set to grow steadily.
End-user Analysis:
Hospitals dominated the end-user segment with a 72.3% revenue share. This is largely because they handle the majority of vascular procedures, including angioplasties and stent placements. The growing number of cardiovascular patients is pushing hospitals to adopt new treatment technologies. Drug-eluting stents, in particular, are widely used to reduce repeat procedures. Hospitals continue to focus on offering efficient and less invasive treatments. As healthcare systems seek better patient outcomes, hospitals are expected to remain the primary users of stents in the years ahead.
Key Market Segments
By Product Type
- Vascular Stents
- Coronary Stents
- Peripheral Stents
- Iliac Artery Stents
- Renal Artery Stents
- Femoral Artery Stents
- Carotid Artery Stents
- Other Peripheral Stents
- Neurovascular Stents
- Intracranial Stents
- Flow Diverters
- Non-vascular Stents
- Gastrointestinal Stents
- Biliary
- Pancreatic
- Esophageal Stents
- Duodenal
- Colonic
- Pulmonary (Airway) Stents
- Silicone Airway
- Metallic Airway
- Urological Stents
- Others
- Gastrointestinal Stents
By Material
- Metallic Stents
- Non-metallic Stents
By End-user
- Hospitals
- Ambulatory Care Centers (ACS)
- Specialty Clinics
Key Players Analysis
Key players in the stent market focus on product innovation, strategic partnerships, and expanding their global presence. They invest heavily in research and development to improve stent design, material durability, and long-term patient outcomes. Collaborations with hospitals and healthcare providers are common, helping to boost adoption rates and improve procedural results. Many companies are targeting emerging markets due to rising healthcare infrastructure and growing awareness. Regulatory approvals and adherence to global standards support the ongoing advancement and market acceptance of new stent technologies.
Abbott Laboratories, headquartered in Abbott Park, Illinois, is a major player in the global stent market. The company offers a broad range of coronary and peripheral stents through its vascular division. Its Xience stent is a key innovation, featuring advanced technology that enhances both safety and effectiveness. Abbott’s growth strategy includes expanding globally through strategic acquisitions and partnerships with healthcare institutions. Its strong focus on innovation and collaboration has positioned it as a leader in the cardiovascular device industry.
Top Key Players in the Stents Market
- Translumina Therapeutics
- Meril Life Science
- Medtronic Plc
- Elixir Medical Corporation
- Boston Scientific Corporation
- Biosensors International Group, Ltd.
- Braun Melsungen AG
- Abbott
Emerging Trends
Shift Towards Biodegradable Stents
More medical companies are focusing on stents that dissolve naturally in the body. These biodegradable stents stay in place just long enough to support the artery. After healing, they safely break down and leave no trace. This helps reduce long-term side effects and complications linked to permanent metal stents. Patients may also avoid the need for additional procedures in the future. The move toward bioresorbable stents reflects a broader shift in healthcare—one that values natural recovery and improved patient comfort. This trend is gaining momentum as research improves and clinical outcomes continue to support this safer alternative.
Focus on Drug-Eluting Stents (DES)
Drug-eluting stents (DES) are becoming the standard in many heart procedures. These stents slowly release medication to prevent the treated artery from narrowing again. The drug coating helps stop cells from growing too quickly around the stent, which can block blood flow. As a result, DES offers better long-term results than bare-metal stents. Doctors also prefer DES for patients at high risk of re-narrowing. With continuous improvements in drug coatings and stent design, these devices are now more effective and reliable. This focus on DES shows how innovation is helping reduce repeat procedures and improve recovery.
Advanced Materials Being Used
Stents are now made from advanced materials that improve both safety and flexibility. Companies are using options like polymer blends, magnesium, and hybrid metals. These materials help the stent bend naturally with the artery and lower the risk of the body rejecting it. Some also dissolve over time, which adds another layer of safety. Lightweight designs reduce strain on the artery, making the procedure smoother. These material innovations help patients recover faster and reduce long-term side effects. As science advances, we will likely see more stents built with smart materials that can adapt to the body more effectively.
Personalized Stent Designs
Medical device companies are moving toward personalized stent designs. Thanks to improved imaging and 3D printing, doctors can now tailor stents to fit each patient’s artery structure. This is especially helpful in complex cases where standard stents don’t work well. Customized stents can reduce the risk of complications and improve blood flow more effectively. The goal is to make treatment as specific as possible, leading to better outcomes. Personalized designs also support the growing trend of precision medicine, where treatment plans are created based on individual needs. This approach marks a big step forward in patient-centered care.
Minimally Invasive Procedures Are Growing
Doctors are now using safer, less invasive methods to place stents. These procedures involve smaller incisions, which means less pain and faster healing. Patients can often go home the same day or within 24 hours. There’s also a lower risk of infection or other complications. With new tools and imaging techniques, doctors can place stents more accurately and efficiently. This has made stent procedures safer and more comfortable for patients. As the technology improves, more hospitals are adopting these minimally invasive methods. The trend supports quicker recovery and lower healthcare costs for both patients and providers.
Expansion Into Emerging Markets
Stent use is rising in developing countries as access to modern healthcare improves. More hospitals and clinics are now offering heart treatments, including stent procedures. Governments and health organizations are investing in better infrastructure and training. This helps expand access to life-saving devices like stents. At the same time, growing awareness about heart health is pushing more people to seek treatment earlier. Lower-cost stent options are also becoming available, making them more affordable in price-sensitive markets. As a result, demand for stents is growing fast in regions like Asia-Pacific, Latin America, and parts of Africa.
Combination Devices Are Emerging
Some companies are creating stents that do more than open blocked arteries. These new stents can include sensors or micro-devices to track blood flow or deliver drugs. This combination of functions helps improve patient care in real time. For example, a stent might detect early signs of blockage and send alerts to doctors. Others might release medication over a longer period based on patient needs. These smart stents are still in development but show great promise. They represent the next level of innovation in medical devices—offering both treatment and monitoring in one solution.
Digital Support & Monitoring
Digital health tools are changing how doctors track recovery after stent placement. Wearable devices and mobile apps now help monitor patients in real time. They track vital signs like heart rate, blood pressure, and activity levels. Doctors can use this data to adjust treatment and catch problems early. Patients also stay more engaged with their care by getting alerts and tips through their phones. This kind of support leads to faster recovery and better results. The use of digital monitoring tools is expected to grow as healthcare moves toward more connected and personalized care.
Use Cases
1. Treating Blocked Arteries in the Heart
One of the most common uses of stents is in the heart. These stents are placed in coronary arteries, which carry blood to the heart muscle. When these arteries become narrow due to plaque buildup, it can reduce blood flow. This may lead to chest pain or heart attacks. A stent helps by opening up the artery and keeping it open. This restores normal blood flow and lowers the risk of future heart issues. It’s often used after a procedure called angioplasty. Heart-related stenting is a life-saving treatment for many patients with coronary artery disease.
2. Peripheral Artery Disease (PAD)
Stents are also used for peripheral artery disease. This condition affects blood flow in arteries outside the heart, especially in the legs. Narrowed or blocked vessels can cause pain and difficulty walking. Stents are inserted to open these arteries and improve circulation. As a result, patients experience less pain and better mobility. PAD is common among older adults and people with diabetes or high blood pressure. Stenting offers a minimally invasive way to relieve symptoms and avoid more invasive surgeries. It improves quality of life and helps maintain limb function over time.
3. Carotid Artery Stenting
Carotid arteries, located in the neck, carry blood to the brain. When plaque builds up in these arteries, it increases the risk of stroke. Carotid artery stenting helps by placing a small mesh tube in the narrowed area. This keeps the artery open and ensures steady blood flow to the brain. It’s often done when surgery isn’t a good option for the patient. The procedure is less invasive and has a quicker recovery time than traditional surgery. It plays a key role in stroke prevention, especially in high-risk patients.
4. Aneurysm Repair
Stents are used to treat aneurysms, which are weak or bulging spots in blood vessels. If left untreated, aneurysms can burst and cause life-threatening bleeding. Special stent grafts are placed inside the blood vessel to support the weak area. These stents act like a scaffold, giving the vessel extra strength. They help prevent rupture and reduce the need for open surgery. Aneurysm repair using stents is common in the aorta, the body’s main artery. The procedure is less risky and recovery is faster compared to traditional surgical repair.
5. Ureteral Stents
Ureteral stents are used in urology to help with urine flow. These thin tubes are placed in the ureters, which are the tubes that carry urine from the kidneys to the bladder. If a stone, tumor, or swelling blocks the ureter, it can cause severe pain or infection. A stent helps by keeping the ureter open so urine can pass freely. This is often a temporary solution used before or after surgery. Ureteral stents are common in patients with kidney stones or after procedures involving the urinary tract.
6. Biliary Stents
Biliary stents are used to treat blockages in the bile ducts. These ducts help carry bile from the liver to the intestines. If a tumor or gallstone blocks the duct, it can cause jaundice, infection, or liver damage. A biliary stent is placed to keep the duct open and allow bile to flow properly. It can be a temporary or long-term solution, depending on the condition. This type of stent is often used in patients with liver cancer, pancreatic cancer, or gallbladder disease. It helps reduce symptoms and prevent complications.
Conclusion
In conclusion, the stents market is growing steadily due to rising heart-related health issues and increased demand for less invasive treatments. New technologies like drug-eluting and biodegradable stents are making procedures safer and recovery faster. Hospitals remain the main users, but more clinics in developing regions are starting to adopt these advanced devices. As more people become aware of heart health and access to care improves, the need for stents will continue to rise. Key players are investing in research and working with healthcare providers to deliver better results. With a focus on innovation and global expansion, the market is set to grow and offer better care options for patients worldwide.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
